{
  "hypothesis": "h571",
  "title": "Therapeutic Island Disease Rescue: Alternative Prediction Strategy",
  "status": "invalidated",
  "date": "2026-02-06",
  "summary": "Therapeutic islands fail because of low drug-sharing with kNN neighbors, NOT drug uniqueness. All 9 islands are 75-100% self-referential. Alternative signals (TransE, gene overlap, drug class) cannot generate NEW predictions \u2014 they only annotate existing kNN predictions. No actionable rescue within current architecture.",
  "islands": [
    {
      "disease": "immunodeficiency",
      "gt_size": 268,
      "holdout": 0,
      "self_ref": 100,
      "medium_plus_preds": 0,
      "failure_mode": "immunological_demotion + rank>20"
    },
    {
      "disease": "ADHD",
      "gt_size": 87,
      "holdout": 0,
      "self_ref": 100,
      "medium_plus_preds": 18,
      "failure_mode": "hierarchy+ATC rules work but kNN is blind"
    },
    {
      "disease": "HCV",
      "gt_size": 50,
      "holdout": 0,
      "self_ref": 100,
      "medium_plus_preds": 2,
      "failure_mode": "disease-specific antivirals not in kNN pool"
    },
    {
      "disease": "PAH",
      "gt_size": 36,
      "holdout": 0,
      "self_ref": 100,
      "medium_plus_preds": 11,
      "failure_mode": "different treatment paradigm than general hypertension"
    },
    {
      "disease": "migraine",
      "gt_size": 35,
      "holdout": 0,
      "self_ref": 100,
      "medium_plus_preds": 2,
      "failure_mode": "triptans/CGRPs not in kNN neighbor pool"
    },
    {
      "disease": "agranulocytosis",
      "gt_size": 31,
      "holdout": 0,
      "self_ref": 83,
      "medium_plus_preds": 0,
      "failure_mode": "hematological_demotion removes all predictions"
    },
    {
      "disease": "narcolepsy",
      "gt_size": 26,
      "holdout": 0,
      "self_ref": 75,
      "medium_plus_preds": 2,
      "failure_mode": "stimulants unique to narcolepsy/ADHD cluster"
    },
    {
      "disease": "DKA",
      "gt_size": 12,
      "holdout": 0,
      "self_ref": 100,
      "medium_plus_preds": 0,
      "failure_mode": "base_to_complication filter + acute vs chronic distinction"
    },
    {
      "disease": "scabies",
      "gt_size": 9,
      "holdout": 0,
      "self_ref": 80,
      "medium_plus_preds": 2,
      "failure_mode": "antiparasitic drugs unique to few diseases"
    }
  ],
  "key_findings": {
    "drug_sharing_not_the_problem": "All 9 diseases have 67-100% of GT drugs shared with other diseases. Drugs ARE in the system.",
    "neighbor_mismatch_IS_the_problem": "kNN neighbors have mean GT overlap of only 0.3-7.2 drugs (vs 6.2-22.6 for high performers). Nearby diseases use different drugs.",
    "embedding_similarity_is_fine": "Islands have mean neighbor similarity 0.498-0.791 (vs 0.412-0.775 for high performers). The embeddings are fine.",
    "alternative_signals_dont_help": "TransE 0%, gene overlap circular with kNN, drug class already exploited. No new signal available.",
    "self_referentiality_confirmed": "All 9 islands are 75-100% self-referential. Predictions vanish entirely when disease is held out.",
    "system_still_works_via_rules": "ADHD has 18 MEDIUM+ predictions, PAH has 11 HIGH predictions \u2014 from hierarchy/ATC rules, not kNN.",
    "holdout_underestimates_quality": "0% holdout is misleading \u2014 PAH has 11 correct HIGH predictions. Holdout penalizes self-referential diseases."
  },
  "implications": [
    "Therapeutic islands require NON-kNN prediction strategy (literature mining, clinical trial data)",
    "Current architecture structurally cannot rescue these diseases",
    "Holdout metric is not appropriate for self-referential diseases \u2014 need alternative quality measure",
    "Drug class expansion (e.g., all triptans for migraine) could help but requires new data infrastructure",
    "Island annotation in deliverable is the best current approach (already implemented)"
  ]
}